FDA issued draft guidance about its plan to develop nonopioid analgesics for acute pain in an effort to spur the development of nonaddictive alternatives.FDA issued draft guidance about its plan to develop nonopioid analgesics for acute pain in an effort to spur the development of nonaddictive alternatives.

HHS, along with leading clinicians, researchers, and policy experts, has established a standard clinical definition for opioid withdrawal in infants. Additionally, they have created a set of foundational principles that highlight bioethical uses for the definition that focus on identifying clinical and supportive care needs for mothers and their infants.

A review in Antimicrobial Agents and Chemotherapy found that the antibiotic development pipeline has comparatively few clinically differentiated products in late-stage clinical development, particularly against critical, multidrug-resistant pathogens.